中轴型脊柱关节炎生活质量差的相关因素:BSRBR-AS 注册研究
基于英国风湿病学会生物制剂注册中轴型脊柱关节炎队列(BSRBR-AS)2012-2017 年招募的 1810 例患者,验证既往模型并构建新模型,发现除疾病活动度和功能外,抑郁、睡眠障碍、活动受限、纤维肌痛及吸烟独立影响 ASQoL 评分。
要点
- 抑郁、睡眠障碍、活动受限、纤维肌痛和吸烟独立预测 ASQoL 评分较差。
- 既往模型中疾病活动度、功能、疲劳和广泛疼痛四个因素得到验证。
- 上述额外因素未被现行 EULAR 指南列为治疗目标。
核心结论
- 中轴型脊柱关节炎患者生活质量差除疾病活动度高和功能差外,还独立受睡眠障碍、情绪和广泛疼痛影响。
研究设计与样本
- 分析英国风湿病学会生物制剂注册中轴型脊柱关节炎队列(BSRBR-AS)2012-2017 年招募的 1810 例患者数据,并验证既往模型。
主要发现
- 既往模型中五个因素中的四个得到确认:Bath 强直性脊柱炎疾病活动指数、Bath 强直性脊柱炎功能指数、疲劳和广泛疼痛。
- 加入情绪和睡眠障碍测量后模型性能改善。
- 新模型中有六个因素(除疾病活动度和功能外)预测 ASQoL:抑郁(β=0.16)、睡眠障碍(β=0.08)、活动受限(β=0.04)、纤维化症状严重度量表(β=0.24)、广泛疼痛指数(β=0.10)和吸烟(β=0.66)。
关键数值与推荐
- 新模型中抑郁 β=0.16、睡眠障碍 β=0.08、活动受限 β=0.04、纤维化症状严重度量表 β=0.24、广泛疼痛指数 β=0.10、吸烟 β=0.66 均预测 ASQoL 评分。
临床怎么用
- 评估中轴型脊柱关节炎患者生活质量时,除疾病活动度和功能外,应关注抑郁、睡眠障碍、活动受限、纤维肌痛和吸烟。
- 上述额外因素未被现行 EULAR 指南列为治疗目标,临床管理可考虑针对这些因素进行干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine modifiable factors associated with poor quality of life (QoL) in patients with axial spondyloarthritis (axSpA). METHODS: Analysis of data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis (BSRBR-AS) and validation of a previous model using data from 1810 patients with axSpA recruited during 2012-2017. Data collected included clinical and patient-reported measures. QoL was assessed using the Ankylosing Spondylitis Quality of Life (ASQoL) measure. Linear regression models predicting ASQoL scores were used first to validate a previous model from a national study, to extend this with additional information available in BSRBR-AS and finally to identify a 'de novo' model from BSRBR-AS of which factors impact on poor QoL. RESULTS: Four out of five factors included in a previous model of poor QoL in patients with axSpA were confirmed: Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index, fatigue and widespread pain, although the performance of the model was improved by the addition of measures of mood and sleep disturbance. In a de novo model in BSRBR-AS, there were six factors (other than disease activity and function) that predicted ASQoL: depression (β=0.16), sleep disturbance (β=0.08), activity impairment (β=0.04), fibromyalgia (Symptom Severity Scale (β=0.24) and Widespread Pain Index (β=0.10)) and tobacco smoking (β=0.66). CONCLUSION: This study confirms that poor QoL in patients with axSpA, in addition to high disease activity and poor function, is independently influenced by sleep disturbance, mood and widespread pain. These additional factors are not considered targets for treatment in current European League Against Rheumatism (EULAR) guidelines for managing the condition.
引用
- Macfarlane GJ, Rotariu O, Jones GT, et al. Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS). Ann Rheum Dis. 2019. PMID: 31662321. doi:10.1136/annrheumdis-2019-216143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。